New therapy for amyotrophic lateral sclerosis successfully tested on mice
Wednesday, February 6, 2019 - 11:40
in Health & Medicine
Researchers have demonstrated the efficacy in mice of a new therapy that addresses the main manifestation of amyotrophic lateral sclerosis (ALS). The researchers developed an antibody that reduces the number of TDP-43 protein aggregates in the brains of mice with ALS, resulting in significant improvements in their cognitive and motor performance.